ZDHHC18 and glioblastoma: In contrast, only a small fraction of ZDHHC18-expressing cells were present in the CD133-positive leading edge of GBM and very few cells expressed ZDHHC23 in the CD44-positive necrotic region of GBM (Additional file 1: Figure S2a).